![](https://webarchive.library.unt.edu/eot2008/20090514050934im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514050934im_/http://www.cancer.gov/images/spacer.gif)
| A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient’s ability to function, or to decide if a patient could be included in a clinical trial. Also called KPS. |
Previous Definitions: | juvenile pilocytic astrocytoma, Kahler disease, Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, karenitecin | Next Definitions: | Kassebaum Kennedy Act, kava kava, keloid, kelp, Kemstro |
|
![](https://webarchive.library.unt.edu/eot2008/20090514050934im_/http://www.cancer.gov/images/spacer.gif) |